GSK raises $1.5 billion from sale of remaining Haleon stake
(Reuters) – British drugmaker GSK has raised 1.25 billion pounds ($1.52 billion) from a sale of its remaining stake in consumer healthcare company Haleon to institutional investors. The sale will allow GSK to sharpen its focus on vaccines, cancer and infectious diseases, which are part of CEO Emma Walmsley’s plans to boost earnings at the …
GSK raises $1.5 billion from sale of remaining Haleon stake Read More »








